Christoph Licht
University of Toronto(CA)Great Ormond Street Hospital(GB)Hospital for Sick Children(CA)SickKids Foundation(CA)University College London(GB)
Publications by Year
Research Areas
Complement system in diseases, Renal Diseases and Glomerulopathies, Adenosine and Purinergic Signaling, Blood groups and transfusion, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome(2013)1,539 cited
- → Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference(2016)680 cited
- → An international consensus approach to the management of atypical hemolytic uremic syndrome in children(2015)574 cited
- → Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test(2017)558 cited
- → Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies(2015)412 cited
- → Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy(2011)354 cited